Neurosilicon

Neurosilicon was a biotechnology company that developed advanced neuro-electronic interfaces for drug discovery and neuroscience research. Spun off from the University of Calgary, the company commercialized a "brain-on-a-chip" technology that allowed for the non-invasive recording and stimulation of neural activity with high spatial resolution. Its core platform utilized novel photoconductive stimulation to target and depolarize specific cells, enabling high-throughput screening for neurological conditions such as epilepsy. The company's tools were designed to provide more accurate in vitro models for assessing drug efficacy and neurotoxicity, bridging the gap between biological neural networks and silicon-based electronics. By providing a platform for bidirectional communication between neurons and semiconductors, Neurosilicon aimed to accelerate the development of therapies for complex brain disorders.